logo

For the Inventor, By the Inventor

Krizevci, Croatia

Tomislav Biljan

This inventor holds 8 USPTO granted patents and 2 published patent applications and 4 EPO patents. Top assignees: Assia Chemical Industries Ltd., Pliva Hrvatska D.o.o., Teva Pharmaceutical Industries Limited. Active years: 2013-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tomislav Biljan. Retrieved from https://idiyas.com/inventor/tomislav-biljan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 

% Patents Active = 75.0

 

Average Co-Inventor Count = 4.7

ph-index = 2

Forward Citations = 13(Granted Patents)


Company Filing History:

goldMedal2 out of 43 
 
Assia Chemical Industries Ltd.
 patents
silverMedal2 out of 13 
 
Pliva Hrvatska D.o.o.
 patents
bronzeMedal2 out of 505 
 
Teva Pharmaceutical Industries Limited
 patents
4. 1 out of 1 
 
Sicor - Societa Italiana Corticosteroidi S.r.l.
 patent
5. 1 out of 834,570 
Other
 patents

Years Active: 2013-2026

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents
1. 12649714 - Process and intermediates for preparation of omaveloxolone and salts thereof (2026-06-09),
2. 11667646 - Solid state forms of rucaparib and of rucaparib salts (2023-06-06),
3. 10875870 - Solid state forms of rucaparib and of rucaparib salts (2020-12-29),
4. 10807953 - Processes and intermediates for the preparation of Pimavanserin (2020-10-20),
5. 10343993 - Processes and intermediates for the preparation of Pimavanserin (2019-07-09),
6. 9012641 - Crystalline forms of Prasugrel salts (2015-04-21),
7. 8802854 - Crystalline forms of Prasugrel salts (2014-08-12),
8. 8501960 - Saxagliptin intermediates, saxagliptin polymorphs, and processes for preparation thereof (2013-08-06),

Title: Tomislav Biljan: Innovator in Pharmaceutical Sciences

Introduction

Tomislav Biljan is a notable inventor based in Krizevci, Croatia. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of solid-state forms of drugs. With a total of seven patents to his name, Biljan's work has had a considerable impact on the industry.

Latest Patents

Among his latest patents are the solid-state forms of rucaparib and its salts. These patents disclose innovative pharmaceutical compositions that enhance the efficacy and stability of rucaparib, a drug used in cancer treatment. The advancements in solid-state forms are crucial for improving drug delivery and patient outcomes.

Career Highlights

Biljan has worked with prominent companies in the pharmaceutical sector, including Teva Pharmaceutical Industries Limited and Pliva Hrvatska d.o.o. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research and development in drug formulation.

Collaborations

Throughout his career, Biljan has collaborated with talented professionals, including Mihaela Tuksar and Jasna Dogan. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Tomislav Biljan's contributions to pharmaceutical sciences through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in drug formulation and delivery systems.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…